These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20558918)

  • 21. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization.
    Bartolozzi C; Lencioni R; Caramella D; Vignali C; Cioni R; Mazzeo S; Carrai M; Maltinti G; Capria A; Conte PF
    Radiology; 1995 Dec; 197(3):812-8. PubMed ID: 7480761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Does interventional radiological treatment (transcatheter arterial chemoembolization/transarterial infusion) improve the prognosis of patients with unresectable and recurrent hepatocellular carcinomas?].
    Shiozawa S; Usui T; Kuhara K; Tsuchiya A; Miyauchi T; Yamaguchi K; Yokomizo H; Shimakawa T; Yoshimatsu K; Katsube T; Naritaka Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1819-21. PubMed ID: 24393933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma].
    Usui T; Shiozawa S; Kim DH; Tsuchiya A; Masuda T; Inose S; Aizawa M; Yoshimatsu K; Katsube T; Naritaka Y; Ogawa K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2702-4. PubMed ID: 21224685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status.
    Kodama K; Kawaoka T; Aikata H; Uchikawa S; Inagaki Y; Hatooka M; Morio K; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Masaki K; Honda Y; Mori N; Takaki S; Tsuji K; Kohno H; Kohno H; Moriya T; Nonaka M; Hyogo H; Aisaka Y; Chayama K
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1780-1786. PubMed ID: 29645345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma.
    Ikeda M; Maeda S; Shibata J; Muta R; Ashihara H; Tanaka M; Fujiyama S; Tomita K
    Oncology; 2004; 66(1):24-31. PubMed ID: 15031595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
    Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T
    Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence.
    Murakami T; Ishimaru H; Sakamoto I; Uetani M; Matsuoka Y; Daikoku M; Honda S; Koshiishi T; Fujimoto T
    Cardiovasc Intervent Radiol; 2007; 30(4):696-704. PubMed ID: 17497071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metronomic S-1 chemotherapy plus transcatheter arterial chemoembolization (TACE): a promising treatment of hepatocellular carcinoma refractory to TACE.
    Huang W; You L; Yang S; Liu D; Liu M; Wang H; Wang P; Baikere P; Gu P; Abulikemu A; Yuan S; Fan X
    J BUON; 2016; 21(4):909-916. PubMed ID: 27685913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma.
    Xu RC; Liu HC; Li JL; Li K; Ou SY; Yu ZY; Kong Y; Ma GA; Shao WS
    Curr Med Res Opin; 2015 Aug; 31(8):1553-60. PubMed ID: 26067770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for the leakage of chemotherapeutic agents into systemic circulation after transcatheter arterial chemoembolization of hepatocellular carcinoma.
    Hsieh MY; Lin ZY; Chen SH; Chuang WL
    Kaohsiung J Med Sci; 2011 Oct; 27(10):431-6. PubMed ID: 21943814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.
    Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1100-8. PubMed ID: 17627902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is Postoperative Adjuvant Transcatheter Arterial Infusion Therapy Effective for Patients with Hepatocellular Carcinoma who Underwent Hepatectomy? A Prospective Randomized Controlled Trial.
    Hirokawa F; Komeda K; Taniguchi K; Asakuma M; Shimizu T; Inoue Y; Kagota S; Tomioka A; Yamamoto K; Uchiyama K
    Ann Surg Oncol; 2020 Oct; 27(11):4143-4152. PubMed ID: 32500344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma.
    Li JH; Xie XY; Zhang L; Le F; Ge NL; Li LX; Gan YH; Chen Y; Zhang JB; Xue TC; Chen RX; Xia JL; Zhang BH; Ye SL; Wang YH; Ren ZG
    World J Gastroenterol; 2015 Apr; 21(13):3970-7. PubMed ID: 25852283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical efficacy and cost benefit of oral antimicrobial prophylaxis with levofloxacin on neurological surgery].
    Akiyama Y; Miyazaki T; Daisu M; Yamamoto Y; Shinguu T; Maruyama N; Nagai H; Moritake K
    No Shinkei Geka; 2006 Jul; 34(7):705-12. PubMed ID: 16841706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma.
    Wu FX; Chen J; Bai T; Zhu SL; Yang TB; Qi LN; Zou L; Li ZH; Ye JZ; Li LQ
    BMC Cancer; 2017 Sep; 17(1):645. PubMed ID: 28899349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postoperative transhepatic arterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma: a randomized study with 131 cases.
    Li Q; Wang J; Sun Y; Cui YL; Juzi JT; Qian BY; Hao XS
    Dig Surg; 2006; 23(4):235-40. PubMed ID: 16943671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are prophylactic antibiotics necessary prior to transarterial chemoembolization for hepatocellular carcinoma in patients with native biliary anatomy?
    Watchmaker JM; Lipnik AJ; Fritsche MR; Baker JC; Mouli SK; Geevarghese S; Banovac F; Omary RA; Brown DB
    J Surg Oncol; 2018 May; 117(6):1312-1317. PubMed ID: 29513895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis.
    Kim JH; Yoon HK; Kim SY; Kim KM; Ko GY; Gwon DI; Sung KB
    Aliment Pharmacol Ther; 2009 Jun; 29(12):1291-8. PubMed ID: 19392861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epirubicin is More Effective than Miriplatin in Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.
    Shirono T; Iwamoto H; Niizeki T; Shimose S; Nakano M; Satani M; Okamura S; Noda Y; Kamachi N; Kuromatsu R; Sakai M; Nomiyama M; Kuwano T; Tanaka M; Koga H; Torimura T
    Oncology; 2019; 96(2):79-86. PubMed ID: 30293080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.